Information Provided By:
Fly News Breaks for July 6, 2015
RPTP
Jul 6, 2015 | 06:05 EDT
Oppenheimer analyst Chris Marai downgraded Raptor Pharmaceuticals to Underperform with an $8 price target. A takeout of the company is unlikely at current valuation levels, Marai tells investors in a research note. He recommends selling the stock.
News For RPTP From the Last 2 Days
There are no results for your query RPTP